144 related articles for article (PubMed ID: 15125966)
1. Design, synthesis, and characterization of an ATP-peptide conjugate inhibitor of protein kinase A.
Hines AC; Cole PA
Bioorg Med Chem Lett; 2004 Jun; 14(11):2951-4. PubMed ID: 15125966
[TBL] [Abstract][Full Text] [Related]
2. Kinetic analysis of inhibition of cAMP-dependent protein kinase catalytic subunit by the peptide-nucleoside conjugate AdcAhxArg6.
Kuznetsov A; Uri A; Raidaru G; Järv J
Bioorg Chem; 2004 Dec; 32(6):527-35. PubMed ID: 15530993
[TBL] [Abstract][Full Text] [Related]
3. Mechanism-based design of a protein kinase inhibitor.
Parang K; Till JH; Ablooglu AJ; Kohanski RA; Hubbard SR; Cole PA
Nat Struct Biol; 2001 Jan; 8(1):37-41. PubMed ID: 11135668
[TBL] [Abstract][Full Text] [Related]
4. Daphnetin, one of coumarin derivatives, is a protein kinase inhibitor.
Yang EB; Zhao YN; Zhang K; Mack P
Biochem Biophys Res Commun; 1999 Jul; 260(3):682-5. PubMed ID: 10403826
[TBL] [Abstract][Full Text] [Related]
5. Functional characterization of peanut serine/threonine/tyrosine protein kinase: molecular docking and inhibition kinetics with tyrosine kinase inhibitors.
Rudrabhatla P; Rajasekharan R
Biochemistry; 2004 Sep; 43(38):12123-32. PubMed ID: 15379551
[TBL] [Abstract][Full Text] [Related]
6. Structural basis of Src tyrosine kinase inhibition with a new class of potent and selective trisubstituted purine-based compounds.
Dalgarno D; Stehle T; Narula S; Schelling P; van Schravendijk MR; Adams S; Andrade L; Keats J; Ram M; Jin L; Grossman T; MacNeil I; Metcalf C; Shakespeare W; Wang Y; Keenan T; Sundaramoorthi R; Bohacek R; Weigele M; Sawyer T
Chem Biol Drug Des; 2006 Jan; 67(1):46-57. PubMed ID: 16492148
[TBL] [Abstract][Full Text] [Related]
7. A highly potent and selective PKCalpha inhibitor generated via combinatorial modification of a peptide scaffold.
Lee JH; Nandy SK; Lawrence DS
J Am Chem Soc; 2004 Mar; 126(11):3394-5. PubMed ID: 15025445
[TBL] [Abstract][Full Text] [Related]
8. Discovery and characterization of a substrate selective p38alpha inhibitor.
Davidson W; Frego L; Peet GW; Kroe RR; Labadia ME; Lukas SM; Snow RJ; Jakes S; Grygon CA; Pargellis C; Werneburg BG
Biochemistry; 2004 Sep; 43(37):11658-71. PubMed ID: 15362850
[TBL] [Abstract][Full Text] [Related]
9. Identification of novel classes of protein kinase inhibitors using combinatorial peptide chemistry based on functional genomics knowledge.
Lukas TJ; Mirzoeva S; Slomczynska U; Watterson DM
J Med Chem; 1999 Mar; 42(5):910-9. PubMed ID: 10072688
[TBL] [Abstract][Full Text] [Related]
10. Kinetic mechanism and inhibitor characterization for c-jun-N-terminal kinase 3alpha1.
Ember B; Kamenecka T; LoGrasso P
Biochemistry; 2008 Mar; 47(10):3076-84. PubMed ID: 18269248
[TBL] [Abstract][Full Text] [Related]
11. Design and crystal structures of protein kinase B-selective inhibitors in complex with protein kinase A and mutants.
Breitenlechner CB; Friebe WG; Brunet E; Werner G; Graul K; Thomas U; Künkele KP; Schäfer W; Gassel M; Bossemeyer D; Huber R; Engh RA; Masjost B
J Med Chem; 2005 Jan; 48(1):163-70. PubMed ID: 15634010
[TBL] [Abstract][Full Text] [Related]
12. Discovery of a novel series of potent and selective substrate-based inhibitors of p60c-src protein tyrosine kinase: conformational and topographical constraints in peptide design.
Alfaro-Lopez J; Yuan W; Phan BC; Kamath J; Lou Q; Lam KS; Hruby VJ
J Med Chem; 1998 Jun; 41(13):2252-60. PubMed ID: 9632358
[TBL] [Abstract][Full Text] [Related]
13. Conjugation of adenosine and hexa-(D-arginine) leads to a nanomolar bisubstrate-analog inhibitor of basophilic protein kinases.
Enkvist E; Lavogina D; Raidaru G; Vaasa A; Viil I; Lust M; Viht K; Uri A
J Med Chem; 2006 Nov; 49(24):7150-9. PubMed ID: 17125267
[TBL] [Abstract][Full Text] [Related]
14. Identification of a highly potent and selective DNA-dependent protein kinase (DNA-PK) inhibitor (NU7441) by screening of chromenone libraries.
Leahy JJ; Golding BT; Griffin RJ; Hardcastle IR; Richardson C; Rigoreau L; Smith GC
Bioorg Med Chem Lett; 2004 Dec; 14(24):6083-7. PubMed ID: 15546735
[TBL] [Abstract][Full Text] [Related]
15. Surface-plasmon-resonance-based biosensor with immobilized bisubstrate analog inhibitor for the determination of affinities of ATP- and protein-competitive ligands of cAMP-dependent protein kinase.
Viht K; Schweinsberg S; Lust M; Vaasa A; Raidaru G; Lavogina D; Uri A; Herberg FW
Anal Biochem; 2007 Mar; 362(2):268-77. PubMed ID: 17274940
[TBL] [Abstract][Full Text] [Related]
16. Enzymatic characteristics of a Ser/Thr protein kinase, SpkA, from Myxococcus xanthus.
Kimura Y; Kakemizu A; Matsubara Y; Takegawa K
J Biosci Bioeng; 2009 Jan; 107(1):10-5. PubMed ID: 19147102
[TBL] [Abstract][Full Text] [Related]
17. Crystal structure of the potent natural product inhibitor balanol in complex with the catalytic subunit of cAMP-dependent protein kinase.
Narayana N; Diller TC; Koide K; Bunnage ME; Nicolaou KC; Brunton LL; Xuong NH; Ten Eyck LF; Taylor SS
Biochemistry; 1999 Feb; 38(8):2367-76. PubMed ID: 10029530
[TBL] [Abstract][Full Text] [Related]
18. Emodin, an anthraquinone derivative isolated from the rhizomes of Rheum palmatum, selectively inhibits the activity of casein kinase II as a competitive inhibitor.
Yim H; Lee YH; Lee CH; Lee SK
Planta Med; 1999 Feb; 65(1):9-13. PubMed ID: 10083837
[TBL] [Abstract][Full Text] [Related]
19. Crystal structures of IRAK-4 kinase in complex with inhibitors: a serine/threonine kinase with tyrosine as a gatekeeper.
Wang Z; Liu J; Sudom A; Ayres M; Li S; Wesche H; Powers JP; Walker NP
Structure; 2006 Dec; 14(12):1835-44. PubMed ID: 17161373
[TBL] [Abstract][Full Text] [Related]
20. Development of a peptide inhibitor-based cantilever sensor assay for cyclic adenosine monophosphate-dependent protein kinase.
Kwon HS; Han KC; Hwang KS; Lee JH; Kim TS; Yoon DS; Yang EG
Anal Chim Acta; 2007 Mar; 585(2):344-9. PubMed ID: 17386684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]